Latest Stock Market News

The CBDT has updated the Capital Gains Accounts Scheme to make it more convenient and digitally accessible. The amendment, effective November 19, extends the scheme to capital gains from shifting industrial units to SEZs under Section 54GA, encouraging such relocations by enabling tax exemptions.

The Reserve Bank of India will ensure banking system liquidity stays above 1% of NDTL. The central bank reassured bankers about its strategy. Recent interventions in the currency spot market and festive season demand caused liquidity to briefly turn negative. The RBI plans to use measures like variable rate reverse repo auctions to maintain liquidity.

Indian stock markets surged on Thursday, approaching record highs. Investor confidence grew as the government signaled progress on a trade pact with the US. The Nifty index briefly surpassed its all-time closing high. Key companies like Eicher Motors and Reliance Industries saw significant gains. Foreign and domestic investors showed strong buying interest. Asian markets also experienced mixed movements.

Nvidia projected strong revenue exceeding analyst expectations, countering AI bubble concerns. The company anticipates a significant revenue surge in upcoming quarters, signaling sustained demand for its AI chips. This positive outlook boosted Nvidia s stock and related tech companies, indicating robust momentum in the AI industry.

Investors seeking high-risk opportunities can consider the Nifty IT index fund. The sector has faced headwinds, leading to underperformance and attractive valuations. Fund managers see this as a good entry point. Indian IT companies are navigating AI s impact, presenting both challenges and opportunities. Global corporations will continue to depend on IT service partners for AI initiatives.

The National Highways Authority of India has appointed Raajmarg Infra Investment Managers as the investment manager for the upcoming Raajmarg Infra Investment Trust. Retail and public investors can expect the first unit issuance in February 2026. Over the next three to five years, approximately 1,500 kilometers of operational national highways will be introduced into the trust, creating significant investment opportunities.

Sudeep Pharma plans to raise ₹95 crore for capex and expand manufacturing capacity by 50,000 tonnes by March 2026. Despite strong export revenue and profit growth, investors may await post-listing performance due to high customer concentration and increased working capital days. The company seeks a P/E multiple of up to 48.

Sudeep Pharma secured strong anchor investor participation ahead of its IPO, attracting major mutual funds, insurers and marquee investors, signalling confidence in its specialised excipient business, global presence and regulatory credentials as it prepares for market debut

Motilal Oswal issued a firm rebuttal to social-media claims alleging misleading research and fund-management practices, asserting the group’s independence, transparency and four-decade commitment to integrity while warning of legal action against those spreading misinformation